Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Dalecarlia Clinical research AB
AB
Active
Org 5569275224
Torggatan 18, 795 30
Rättvik
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2013
0 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Dalecarlia Clinical research AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
1M
2M
3M
5M
2M
2020
4M
2021
1M
2022
2M
2023
2M
2024
EBITDA
SEK millions
0M
1M
1M
2M
2M
0M
2020
2M
2021
0M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
2 102
3 744
1 485
1 963
1 543
Staff expenses
—
—
—
—
—
EBITDA
229
1 647
−115
383
101
Depreciation & amort.
−23
−17
−27
−31
−4
EBIT
206
1 630
−142
352
97
Net financials
−7
−6
−9
−9
−15
Profit before tax
199
1 217
−128
343
82
Tax
−44
−253
−0
−49
−21
Net profit
155
964
−128
294
61
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
1 066
2 274
1 599
1 764
1 918
Equity
480
1 194
630
735
796
Long-term debt
0
0
0
0
0
Short-term debt
454
542
453
513
606
Total debt
454
542
453
513
606
Financial ratios
5-year trend
EBITDA margin
6.5%
This company
15.8%
Market median
-59% vs market
2020
2024
Equity ratio
41.5%
This company
38.2%
Market median
+9% vs market
2020
2024
Return on equity
7.7%
This company
18.4%
Market median
-58% vs market
2020
2024
Net profit margin
4.0%
This company
8.1%
Market median
-51% vs market
2020
2024
Asset turnover
0.80×
This company
1.12×
Market median
-29% vs market
2020
2024
Debt / equity
1.41×
This company
0.62×
Market median
-127% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Dalecarlia Clinical research AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
